Development and Internal Validation of a Multivariable Prediction Model for Mortality After Hip Fracture with Machine Learning Techniques
Calcified Tissue International · 2024
DOI: 10.1007/s00223-024-01208-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Calcified Tissue International, 2024. Verfasst von Mathias Mosfeldt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Karolinska University Hospital, Stockholm, Sweden. mathias.mosfeldt@ki.se. Hauptthemen laut MEDLINE: Hip Fractures, Machine Learning. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institute.
Abstract (Originalsprache)
In order to estimate the likelihood of 1, 3, 6 and 12 month mortality in patients with hip fractures, we applied a variety of machine learning methods using readily available, preoperative data. We used prospectively collected data from a single university hospital in Copenhagen, Denmark for consecutive patients with hip fractures, aged 60 years and older, treated between September 2008 to September 2010 ( n = 1186). Preoperative biochemical and anamnestic data were used as predictors and outcome was survival at 1, 3, 6 and 12 months after the fracture. After feature selection for each timepoint a stratified split was done (70/30) before training and validating Random Forest models, extreme gradient boosting (XGB) and Generalized Linear Models. We evaluated and compared each model using receiver operator characteristic (ROC), calibration slope and intercept, Spiegelhalter’s z- test and Decision Curve Analysis. Using combinations of between 10 and 13 anamnestic and biochemical parameters we were able to successfully estimate the likelihood of mortality with an area under the curve on ROC curves of 0.79, 0.80, 0.79 and 0.81 for 1, 3, 6 and 12 month, respectively. The XGB was the overall best calibrated and most promising model. The XGB model most successfully estimated the likelihood of mortality postoperatively. An easy-to-use model could be helpful in perioperative decisions concerning level of care, focused research and information to patients. External validation is necessary before widespread use and is currently underway, an online tool has been developed for educational/experimental purposes ( https://hipfx.shinyapps.io/hipfx/ ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics, Karolinska University Hospital, Stockholm, Sweden. mathias.mosfeldt@ki.se.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. mathias.mosfeldt@ki.se.
- Department of Clinical Biochemistry, Hvidovre Hospital, Hvidovre, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Orthopaedic Surgery, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Mathias Mosfeldt
Förderung
- Karolinska Institute
Zitieren
APA
Mosfeldt, M., Jørgensen, H. L., Lauritzen, J. B., & Jansson, K. Å. (2024). Development and Internal Validation of a Multivariable Prediction Model for Mortality After Hip Fracture with Machine Learning Techniques. Calcified Tissue International. https://doi.org/10.1007/s00223-024-01208-1
Vancouver
Mosfeldt M, Jørgensen HL, Lauritzen JB, Jansson KÅ. Development and Internal Validation of a Multivariable Prediction Model for Mortality After Hip Fracture with Machine Learning Techniques. Calcified Tissue International. 2024. doi:10.1007/s00223-024-01208-1
BibTeX
@article{Mosfeldt2024,
author = {Mosfeldt, Mathias and Jørgensen, Henrik Løvendahl and Lauritzen, Jes Bruun and Jansson, Karl-Åke},
title = {Development and Internal Validation of a Multivariable Prediction Model for Mortality After Hip Fracture with Machine Learning Techniques},
journal = {Calcified Tissue International},
year = {2024},
doi = {10.1007/s00223-024-01208-1}
}
EUVIMED